Your browser doesn't support javascript.
loading
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
Strowd, Roy; Ellingson, Benjamin; Raymond, Catalina; Yao, Jingwen; Wen, Patrick Y; Ahluwalia, Manmeet; Piotrowski, Anna; Desai, Arati; Clarke, Jennifer L; Lieberman, Frank S; Desideri, Serena; Nabors, L Burt; Ye, Xiaobu; Grossman, Stuart.
Afiliação
  • Strowd R; Wake Forest University School of Medicine, 1 Medical Center Boulevard, Winston Salem, NC, 27104, USA. rstrowd@wakehealth.edu.
  • Ellingson B; University of California Los Angeles, Los Angeles, CA, USA.
  • Raymond C; University of California Los Angeles, Los Angeles, CA, USA.
  • Yao J; University of California Los Angeles, Los Angeles, CA, USA.
  • Wen PY; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ahluwalia M; Cleveland Clinic, Cleveland, OH, USA.
  • Piotrowski A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Desai A; University of Pennsylvania, Philadelphia, PA, USA.
  • Clarke JL; University of California San Francisco, San Francisco, CA, USA.
  • Lieberman FS; University of Pittsburgh, Pittsburgh, PA, USA.
  • Desideri S; Johns Hopkins Hospital, Baltimore, MD, USA.
  • Nabors LB; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Ye X; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USA.
  • Grossman S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, USA.
J Neurooncol ; 165(1): 101-112, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37864646

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article